The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.

CVS Health’s stock falls as a large charge to write off the value of an underperforming business takes the shine off an ...

CVS Health projected double-digit earnings growth for 2026 on Wednesday after raising its 2025 profit forecast for the third ...

Discover why CVS Health Corporation is rated a Buy, offering 18% upside, robust growth, and a 3.25% yield. Click for more on ...

CVS Health management raised 2025 EPS guidance, projecting robust double-digit earnings growth. Click here to read why CVS stock is a Buy.

If you’ve been making mental notes to pick up prescriptions at your usual CVS or Walgreens, you might want to check whether ...

CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting the overall contribution to support Feeding ...

CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.

This story was updated following CVS Health's earnings call Wednesday morning. | The company reported improvements in its ...

USC researchers are launching a major reboot of their pharmacy desert mapping tool - at a time of accelerating pharmacy closures nationwide - in hopes ...

With the recent news of pharmacy closures as a result of Rite Aid’s bankruptcy, a local independent pharmacist is going ...

Next, Wednesday got me trembling in anticipation. Why? Well, this morning has a sure winner in CVS, at least from my point of ...